Demo Sign up Log In

Denali Therapeutics Inc (DNLI)

Cash Conversion Ratio

0.77×

Quarterly · Period ending: Jun 30, 2026

DNLI Cash Conversion Ratio

Latest reported0.77×period endingJun 30, 2026

Latest reported0.77×period endingJun 30, 2026

DNLI Quarterly Cash Conversion Ratio (-1.40× → 0.77×)

Latest values, visible window

High-resolution chart · PNG

DNLI cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Denali Therapeutics Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2026	0.7668×
Sep 30, 2023	0.9001×
Jun 30, 2023	-0.649×
Mar 31, 2023	0.561×
Dec 31, 2022	0.7855×
Sep 30, 2022	0.6108×
Jun 30, 2022	0.7788×
Mar 31, 2022	1.1676×
Dec 31, 2021	0.9108×
Sep 30, 2021	0.512×
Jun 30, 2021	0.9061×
Mar 31, 2021	0.7573×
Dec 31, 2020	2.0937×
Sep 30, 2020	0.0106×
Jun 30, 2020	0.7433×
Mar 31, 2020	0.9755×
Dec 31, 2019	0.9332×
Sep 30, 2019	0.7195×
Jun 30, 2019	0.9162×
Mar 31, 2019	0.8297×
Dec 31, 2018	1.1833×
Sep 30, 2018	1.0084×
Jun 30, 2018	0.7747×
Mar 31, 2018	-1.3954×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.